Joycelynne M Palmer Selected Research

Joycelynne M Palmer Research Topics

6	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 07/2011
4	Graft vs Host Disease (Graft-Versus-Host Disease) 01/2022 - 06/2009
4	Multiple Myeloma 07/2018 - 01/2014
4	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2017 - 01/2008
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2015 - 08/2008
2	Infections 01/2023 - 06/2009
2	Neoplasms (Cancer) 01/2023 - 01/2017
2	Lymphoma (Lymphomas) 01/2017 - 12/2014
2	Philadelphia Chromosome 07/2015 - 08/2008
1	COVID-19 01/2023
1	Breast Neoplasms (Breast Cancer) 01/2023
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2022
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 01/2018
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2018
1	Residual Neoplasm 01/2018
1	Pathologic Complete Response 12/2015
1	Chromosome Aberrations (Chromosome Abnormalities) 07/2015
1	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 03/2012
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 10/2011
1	T-Cell Lymphoma (Lymphoma, T Cell) 10/2011
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 10/2011
1	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 04/2011
1	Thrombotic Microangiopathies 02/2010
1	Disease Progression 10/2007
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 10/2007

4	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 01/2008
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022 - 02/2010
3	Brentuximab VedotinIBA 12/2015 - 06/2012
2	Dexamethasone (Maxidex)FDA LinkGeneric 01/2023 - 07/2018
2	plerixafor FDA Link 09/2017 - 01/2014
2	Sirolimus (Rapamycin)FDA Link 02/2016 - 02/2010
2	Tacrolimus (Prograf)FDA LinkGeneric 02/2016 - 02/2010
2	Carmustine (FIVB)FDA Link 12/2014 - 01/2008
2	Yttrium-90IBA 12/2014 - 01/2008
2	Melphalan (Alkeran)FDA LinkGeneric 12/2014 - 01/2008
2	ibritumomab tiuxetan (Zevalin)FDA Link 12/2014 - 01/2008
2	Cytarabine (Cytosar-U)FDA LinkGeneric 12/2014 - 01/2008
1	remdesivirIBA 01/2023
1	Leflunomide (Arava)FDA LinkGeneric 01/2023
1	VaccinesIBA 01/2023
1	Ifosfamide FDA LinkGeneric 01/2022
1	NivolumabIBA 01/2022
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	IceIBA 01/2022
1	pomalidomideIBA 07/2018
1	Lenalidomide (CC 5013)FDA Link 07/2018
1	ixazomibIBA 07/2018
1	Bortezomib (Velcade)FDA Link 01/2018
1	daratumumabIBA 01/2018
1	CopperIBA 01/2018
1	Rituximab (Mabthera)FDA Link 01/2018
1	Messenger RNA (mRNA)IBA 01/2018
1	Cyclin D1IBA 01/2018
1	Tyrosine Kinase InhibitorsIBA 07/2015
1	N 30IBA 10/2011
1	fludarabineIBA 04/2011
1	Busulfan (Busulfex)FDA Link 02/2010
1	SteroidsIBA 06/2009

10	Cell Transplantation 01/2022 - 08/2008
6	Therapeutics 01/2023 - 10/2007
6	Stem Cell Transplantation 01/2018 - 10/2007
5	Drug Therapy (Chemotherapy) 01/2017 - 01/2008
3	Homologous Transplantation 01/2022 - 06/2012
2	Transplantation 01/2022 - 01/2008
2	Autologous Transplantation 12/2015 - 12/2014
1	Lymphatic Irradiation 01/2022
1	Salvage Therapy 01/2022
1	Combination Drug Therapy (Combination Chemotherapy) 12/2015
1	Radioimmunotherapy 03/2012
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 11/2009
1	Hematopoietic Stem Cell Transplantation 06/2009
1	Radiotherapy 01/2008